Wednesday, February 06, 2019 10:31:31 PM
Looks like another losing Day for market timers.
OTFLMAO!!
Meanwhile the truth: Chart looking Good! Uplist next!!
Looking at that 1 yr chart CVSI looks currently average at best. It climbed fast over 8 months, traded sideways for the next six and down drastically recently. Looking at this 4 day chart, CVSI is Down in the RED 16.6% - Yep, you’re reading it right, down 16.6% over FOUR DAYS since last Friday. Perfect day trading opportunity, perfect market timing, perfect time to load up and score on CVSI my 18th time. Not so great for those who are “Long.” You should have sold in August like I did. Today I bought CVSI for $4.85 and tomorrow thanks to Popeye for between $4.50 and $4.70, soon thereafter to sell for another quick $10,000.00 to $20,000.00 - CVSI is a market timing, day traders dream! It’s so predictable. You rarely see that particularly on the OTC. I added to the 114,650 shares of CVSI I bought for $.41 the first week of January 2018 and sold @ $6.98 in August of 2018. A few more days like these and I’ll be up a mil on what was basically a second thought. Jefra ran it by me last December. CVSI has been a day traders dream. Meanwhile the real truth, As far as CVSI trading on a real stock exchange, unfortunately that will never happen, not ever. No matter how many tics of the clock go bye. We’re up to almost 7 months of ticking and rocking but no CVSI “uplist.”
CVSI makes me so happy I’m OTFLMAO!
Minds are like parachutes: they only function when they're open
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
